TAURIGA SCIENCES, INC. (80)

Browse by Contract Category

Contracts

Lease agreement for corporate headquarters dated January 6, 2021 (Filed With SEC on January 8, 2021)
Master Services Agreement between the Company and Clinical Strategies & Tactics, Inc., dated December 16, 2020 (Filed With SEC on December 29, 2020)
Promissory Note between the Company and Tangiers Global, LLC consummated on December 21, 2020 (Filed With SEC on December 29, 2020)
License Agreement between Think Big, LLC and Tauriga Sciences, Inc., dated September 24, 2020 (Filed With SEC on October 1, 2020)
Consulting Agreement, dated July 15, 2020, by and between the Company and Dr. Keith Aqua (Filed With SEC on July 22, 2020)
Mr. Checkout distributor agreement dated June 29, 2020 (Filed With SEC on July 14, 2020)
Joint Venture Partnership agreement between the Company and OG Labratories, LLC dated January 21, 2020 (Filed With SEC on February 13, 2020)
Amendment to Registration Rights Agreement, dated November 18, 2020 (Filed With SEC on November 19, 2020)
Amendment to Investment Agreement, dated November 18, 2020 (Filed With SEC on November 19, 2020)
Inventory Financing Promissory Note for $135,000 dated October 5, 2020 with Jefferson St. Capital LLC (Filed With SEC on November 16, 2020)
Securities Purchase Agreement with Jefferson Street Capital, LLC date October 5, 2020 (Filed With SEC on November 16, 2020)
Form of Private Placement Stock sale agreements for shares issued and funds received (Filed With SEC on November 16, 2020)
Professional Services Agreement between Christopher J. Wllace and Tauriga Sciences, Inc., dated September 24, 2020 (Filed With SEC on October 1, 2020)
Professional Services Agreement between Willie C. Mack, Jr. and Tauriga Sciences, Inc., dated September 24, 2020 (Filed With SEC on October 1, 2020)
Amended Collaboration agreement with Aegea Biotechnologies Inc. dated August 10, 2020 (Filed With SEC on August 14, 2020)
Product Placement Membership Agreement between the Company and KushCo Holdings, Inc., dated July 10, 2020 (Filed With SEC on July 14, 2020)
Convertible Note between the Company and GS Capital LLC dated June 4, 2020 (Filed With SEC on July 14, 2020)
Securities Purchase Agreement between the Company and GS Capital LLC dated June 4, 2020 (Filed With SEC on July 14, 2020)
Form of Securities Purchase agreement between Aegea Biotechnologies, Inc (Filed With SEC on June 29, 2020)
Tangiers Global, LLC 8% Fixed Convertible Note for $210,000 dated June 24, 2020 (Filed With SEC on June 29, 2020)
Distribution Agreement between the Company and Sai Krishna LLC, dated April 30, 2019 filed on Current Report 8-K on May 3, 2019 (Filed With SEC on June 29, 2020)
Warrant Subscription Agreement with VistaGen Therapeutics, Inc. dated December 6, 2019 (Filed With SEC on June 29, 2020)
Convertible Note between the Company and Adar Alef, LLC, dated April 30, 2020 (Filed With SEC on June 3, 2020)
Securities Purchase Agreement between the Company and Adar Alef, LLC, dated April 30, 2020 (Filed With SEC on June 3, 2020)
Convertible Note between the Company and GS Capital LLC dated April 17, 2020 (Filed With SEC on June 3, 2020)
Securities Purchase Agreement between the Company and GS Capital LLC dated April 17, 2020 (Filed With SEC on June 3, 2020)
Convertible Note between the Company and Tangiers Global, LLC dated March 23, 2020 (Filed With SEC on June 3, 2020)
Convertible Note between the Company and Firstfire Global Opportunities Fund, LLC dated May 18, 2020 (Filed With SEC on June 3, 2020)
Securities Purchase Agreement between the Company and Firstfire Global Opportunities Fund, LLC dated May 18, 2020 (Filed With SEC on June 3, 2020)
Securities Purchase Agreement between the Company and Adar Alef, LLC, dated March 17, 2020 (Filed With SEC on April 15, 2020)
Collaboration Agreement with Aegea Biotechnologies Inc. dated April 3, 2020 (Filed With SEC on April 15, 2020)
Convertible Note between the Company and Adar Alef, LLC, dated March 17, 2020 (Filed With SEC on April 15, 2020)
Convertible Note between the Company and Tangiers Global, LLC dated March 23, 2020 (Filed With SEC on April 15, 2020)
Amended and Restated 10% Fixed Convertible Promissory Note in the principal amount of $137,500 dated February 28, 2020 (Filed With SEC on March 5, 2020)
Crown Bridge Partners, LLC $55,000 one-year 10% Convertible Promissory Note dated February 11, 2020 (Filed With SEC on March 5, 2020)
Securities Purchase Agreement between the Company and Adar Alef, LLC, dated January 15, 2020 (Filed With SEC on February 13, 2020)
Convertible Note between the Company and Adar Alef, LLC, dated January 15, 2020 (Filed With SEC on February 13, 2020)
Tangiers Global, LLC 10% Convertible Promissory Note effective February 7, 2020 (Filed With SEC on February 13, 2020)
Investment Agreement between Tangiers Global, LLC and the Company, dated January 21, 2020 (Filed With SEC on January 29, 2020)
Convertible Note between the Company and GS Capital Partners, dated January 17, 2020 (Filed With SEC on January 29, 2020)
Securities Purchase Agreement between the Company and GS Capital Partner, dated January 17, 2020 (Filed With SEC on January 29, 2020)
Registration Rights Agreement, dated January 21, 2020 (Filed With SEC on January 29, 2020)
Convertible Promissory Note issued to BHP Capital NY Inc., dated January 3, 2020 (Filed With SEC on January 9, 2020)
Securities Purchase Agreement between BHP Capital NY INC and the Company, dated January 3, 2020 (Filed With SEC on January 9, 2020)
Securities Purchase Agreement, December 2019 private placement (Filed With SEC on January 9, 2020)
Convertible Redeemable Note issued to Jefferson Street Capital LLC, dated December 26, 2019 (Filed With SEC on January 9, 2020)
Securities Purchase Agreement between Jefferson Street Capital LLC and the Company, dated December 26, 2019 (Filed With SEC on January 9, 2020)
Convertible Redeemable Note issued to Odyssey Capital, LLC, dated December 18, 2019 (Filed With SEC on January 9, 2020)
Securities Purchase Agreement between Odyssey Capital, LLC and the Company, dated December 18, 2019 (Filed With SEC on January 9, 2020)
Tangiers Global, LLC 10% Convertible Promissory Note dated November 5, 2019 (Filed With SEC on November 12, 2019)
BHP Capital NY, Inc Convertible Promissory note dated October 17, 2019 (Filed With SEC on November 12, 2019)
BHP Capital NY, Inc. Securities Purchase Agreement dated October 7, 2019 (Filed With SEC on November 12, 2019)
Securities Purchase Agreement between Odyssey Funding, LLC and the Company, dated September 13, 2019 (Filed With SEC on October 8, 2019)
Convertible Redeemable Note issued to Odyssey Funding, LLC, dated September 13, 2019 (Filed With SEC on October 8, 2019)
Agreement with Vice President of Distribution & Marketing date May 11, 2019 (Filed With SEC on August 13, 2019)
Jefferson St. Capital, LLC Convertible note dated July 22, 2019 for $55,000 (Filed With SEC on August 13, 2019)
Jefferson St. Capital LLC Securities Purchase Agreement note dated July 22, 2019 for $55,000 (Filed With SEC on August 13, 2019)
Distribution Agreement between the Company and Windmill Health Products, LLC, dated June 28, 2019 (Filed With SEC on July 5, 2019)
GS Capital Partners, LLC Securities Purchase Agreement dated June 21, 2019 (Filed With SEC on June 27, 2019)
GS Capital Partners, LLC Convertible note dated March 14, 2019 for $300,000 (Filed With SEC on June 27, 2019)
GS Capital Partners, LLC Securities Purchase Agreement dated March 14, 2019 (Filed With SEC on June 27, 2019)
GS Capital Partners, LLC Securities Purchase Agreement dated May 23, 2019 (Filed With SEC on June 27, 2019)
GS Capital, LLC Convertible note dated May 23, 2019 for $60,000 (Filed With SEC on June 27, 2019)
GS Capital Partners, LLC Convertible note dated June 21, 2019 for $60,000 (Filed With SEC on June 27, 2019)
Distribution Agreement between the Company and Sai Krishna LLC, dated April 30, 2019 (Filed With SEC on May 3, 2019)
Securities Purchase Agreement (GS Capital Note), dated March 14, 2019 (Filed With SEC on April 15, 2019)
Distribution Agreement between the Company and E&M Ice Cream Co., dated April 1, 2019 (Filed With SEC on April 15, 2019)
Distribution Agreement between the Company and IRM Management Corporation, dated April 8, 2019 (Filed With SEC on April 15, 2019)
GS Capital Note, dated March 14, 2019 (Filed With SEC on April 15, 2019)
SECURITIES PURCHASE AGREEMENT Tauriga Sciences Inc. (OTCQB: TAUG) 555 Madison Avenue, 5th Floor New York, NY 10022 Attn: Seth M. Shaw, Chief Executive Officer. DATE: March ____,... (Filed With SEC on April 15, 2019)
Securities Purchase Agreement with Eagle Equities LLC consummated January 23, 2019 concerning the $62,000 convertible note (Filed With SEC on January 29, 2019)
Securities purchase agreement dated January 8, 2019 for 1,000,000 shares at $0.02 (Filed With SEC on January 29, 2019)
January 11, 2019 consulting agreement for 1,250,000 restricted common shares (Filed With SEC on January 29, 2019)
Manufacturing agreement with Per Os Biosciences dated December 28, 2018 (Filed With SEC on January 29, 2019)
Collateralized secured promissory note from Adar Alef dated December 20, 2019 (Filed With SEC on January 29, 2019)
One year 8% Convertible back-end note with Adar Alef dates December 20, 2018 (Filed With SEC on January 29, 2019)
One year 8% Convertible note with Adar Alef dates December 20, 2018 (Filed With SEC on January 29, 2019)
Securities purchase agreement with Adar Alef dates December 20, 2018 (Filed With SEC on January 29, 2019)
Side letter agreement dated January 18, 2019 to the $62,000 Convertible note with Eagle Equities LLC consummated January 23,2019 (Filed With SEC on January 29, 2019)
Convertible note consummated January 23, 2019 for $62,000 with Eagle Equities LLC (Filed With SEC on January 29, 2019)